Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
NCT00105287
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Cancer
Interventions
DRUG:
OraVescent fentanyl (OVF)
Sponsor
Cephalon